8-K: Anteris Technologies Appoints New CFO
Current Report (Form 8-K)
Anteris Technologies Global Corp. has announced the appointment of Brent Moen as its new Chief Financial Officer, effective September 11, 2026.
Summary
- Anteris Technologies Global Corp. has appointed Brent Moen as its new Chief Financial Officer (CFO), effective September 11, 2026.
- Mr. Moen, 59, brings over 25 years of financial leadership experience, including previous CFO roles at public and private companies, with expertise in capital markets, investor relations, M&A, and scaling growth-oriented organizations, particularly in medical technology.
- His prior roles include CFO at LifeLens Technologies, Tactile Systems Technology, and Entellus Medical.
- Mr. Moen's compensation package includes an annual base salary of $475,000, a short-term annual bonus opportunity of up to 50% of his base salary, and eligibility for long-term incentive awards, including a 2026 award with a target value of $500,000.
- He will also receive nonqualified stock options with a target value of $500,000, vesting over three years.
- In connection with his transition, Matthew McDonnell will move from CFO to Head of Australia, effective September 11, 2026, continuing his employment under current arrangements.
- The filing also includes the standard employment agreement details, including confidentiality, non-solicitation, and severance provisions.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive development, indicating a strategic strengthening of the financial leadership team with an experienced executive.
Positives
- Appointment of an experienced CFO with a strong track record in medical technology and capital markets.
- The new CFO, Brent Moen, has over 25 years of relevant leadership experience.
- A comprehensive compensation package including base salary, bonus potential, and significant long-term equity incentives ($500,000 target value).
- The transition plan for the outgoing CFO, Matthew McDonnell, to Head of Australia suggests continuity and internal development.
Negatives
- The filing does not contain any negative financial results or operational setbacks.
- The primary focus is on a personnel change, not a financial performance update.
Risks
- Potential for disruption during the initial transition period of the new CFO, although the agreement aims to mitigate this.
- The standard risks associated with any executive employment agreement, including confidentiality and non-solicitation clauses, which could lead to disputes if breached.
Future Outlook
The filing primarily concerns a management appointment and does not contain specific forward-looking financial guidance. However, the appointment of an experienced CFO suggests a focus on strengthening financial operations and strategic execution for future growth.
Management Comments
- The filing does not contain direct quotes from management, but details the terms of the employment agreement.
- The agreement outlines the duties of the CFO, reporting to the CEO, and the expectation of full-time dedication to the Company's business.
Industry Context
StockSavvy.ai notes that the appointment of a seasoned CFO is a common and positive step for companies, especially those in growth phases or the medical technology sector, aiming to enhance financial strategy, investor relations, and operational scaling.
Comparison to Industry Standards
- The base salary of $475,000 for a CFO in a publicly traded company (listed on Nasdaq) is within the typical range, depending on the company's size and stage.
- The bonus structure (up to 50% of base salary) and long-term incentive awards (target $500,000) are also standard for senior executive compensation in the technology and medical device sectors.
- Severance packages of nine months' salary and COBRA continuation are common, though the specifics can vary widely.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Matthew McDonnell | Brent Moen | 2026-09-11 | Strategic appointment of new CFO |
| Head of Australia | N/A | Matthew McDonnell | 2026-09-11 | Transition from CFO role |
Stakeholder Impact
- Shareholders: The appointment of an experienced CFO is generally viewed positively, potentially leading to improved financial management and strategic execution, which could benefit shareholder value.
- Employees: The transition of Matthew McDonnell to Head of Australia may signal a strategic focus on the Australian market or a restructuring of regional leadership.
- Management: The new CFO brings a wealth of experience that can support the executive team in achieving company objectives.
Next Steps
- Brent Moen to commence duties as CFO on September 11, 2026.
- Matthew McDonnell to commence duties as Head of Australia on September 11, 2026.
- The Company will continue to operate under its established financial and operational strategies.
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Date of Report and date of Employment Agreement |
| 2026-09-11 | Effective date of Brent Moen's appointment as CFO and start of Employment Period |
| 2026-12-31 | End of the 2026 calendar year for prorated bonus calculation |
Recommendation
holdThis filing announces a key executive appointment rather than financial results or strategic shifts that would directly impact the stock price. While the appointment of an experienced CFO is positive, it warrants a 'hold' recommendation pending further operational or financial updates from the company.
Keywords
Chief Financial Officer, CFO Appointment, Executive Compensation, Employment Agreement, Anteris Technologies, Brent Moen, Matthew McDonnell, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.